Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA

Open source

DOI: 10.1186/s12885-016-2163-y
Published: 2016 Feb 17
Container: BMC cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-016-2163-y,
  title = {Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.},
  author = {Proskurina AS and Gvozdeva TS and Alyamkina EA and Dolgova EV and Orishchenko KE and Nikolin VP and Popova NA and Sidorov SV and Chernykh ER and Ostanin AA and Leplina OY and Dvornichenko VV and Ponomarenko DM and Soldatova GS and Varaksin NA and Ryabicheva TG and Uchakin PN and Zagrebelniy SN and Rogachev VA and Bogachev SS and Shurdov MA},
  year = {2016},
  journal = {BMC cancer},
  doi = {10.1186/s12885-016-2163-y},
  url = {https://doi.org/10.1186/s12885-016-2163-y}
}

RIS

TY  - JOUR
TI  - Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.
AU  - Proskurina AS
AU  - Gvozdeva TS
AU  - Alyamkina EA
AU  - Dolgova EV
AU  - Orishchenko KE
AU  - Nikolin VP
AU  - Popova NA
AU  - Sidorov SV
AU  - Chernykh ER
AU  - Ostanin AA
AU  - Leplina OY
AU  - Dvornichenko VV
AU  - Ponomarenko DM
AU  - Soldatova GS
AU  - Varaksin NA
AU  - Ryabicheva TG
AU  - Uchakin PN
AU  - Zagrebelniy SN
AU  - Rogachev VA
AU  - Bogachev SS
AU  - Shurdov MA
PY  - 2016
JO  - BMC cancer
DO  - 10.1186/s12885-016-2163-y
UR  - https://doi.org/10.1186/s12885-016-2163-y
ER  -

APA

AS, P., TS, G., EA, A., EV, D., KE, O., VP, N., NA, P., SV, S., ER, C., AA, O., OY, L., VV, D., DM, P., GS, S., NA, V., TG, R., PN, U., SN, Z., VA, R., SS, B., & MA, S. (2016). Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.. BMC cancer. https://doi.org/10.1186/s12885-016-2163-y

Source records

pubmed · retrieved 2026-09-27T11:52:01.773Z